Industry veteran in oncology antibody discovery & development Dr Haijun Sun appointed Chief Scientific Officer Expansion of the Scientific Advisory Board with appointments of leading experts in preclinical, translational and clinical drug development Barcelona, Spain, 21 October 2021: ONA Therapeutics (“ONA”), which is focused on the discovery and development… Read More
Barcelona, Spain, March 5th, 2021: Ona Therapeutics, a company focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announces today that it has appointed Dr. Mark Throsby as independent board member of its Board of Directors. Dr. Throsby is a proven senior executive with more than… Read More
Barcelona, Spain, December, 16 2020. ONA Therapeutics, Absolute Antibody and RIC – three leading European companies in the biotech landscape – have been awarded a Eurostars grant for a two-year project that will develop a proprietary biological drug with a unique mode of action for the treatment of various types… Read More
1st December 2020. Fondation Bettencourt Schueller, Neuilly-sur-Seine, Hauts de Seine, France (https://www.fondationbs.org/en/life-sciences) ONA’s scientific co-founder Salvador Aznar Benitah has been awarded with the LILIANE BETTENCOURT prize for life sciences. Read more information about this award here. Read More
Barcelona, Spain – 28 September 2020 – Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer, today announced that it has been named by Fierce Biotech as one of 2020’s Fierce 15 biotechnology companies, designating it as one of the… Read More
Barcelona, Spain, June 16th 2020: Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announces today the closing of a €30 million Series A financing, with participation from existing investor Asabys Partners and new investors Alta Life Sciences, Bpifrance – InnoBio 2,… Read More
Salvador Aznar Benitah, Group Leader del Stem Cells and Cancer Laboratory del IRB Barcelona y cofundador de la spin-off Ona Therapeutics. Investigador ICREA, Aznar llegó al IRB Barcelona hace seis años. Su trabajo ha estado focalizado en entender cómo se regeneran los tejidos humanos. Cómo las células madre lidian… Read More
Lyfebulb and Helsinn Announce 11 Finalists for the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award MONACO, PRINCIPALITY OF MONACO, AND NEW YORK, NY, USA, January 14, 2020: Lyfebulb, a patient empowerment platform that connects patients with industry to support user-driven innovation toward solutions in chronic disease, and Helsinn, a… Read More
ONA Therapeutics will pitch at the Biotech Showcase 2020 at San Francisco during the 38th Annual J.P. Morgan Healthcare Conference. The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members… Read More
Barcelona has woven an advanced ecosystem around the birth and promotion of new technology, biotechnology and industrial companies. ONA Therapeutics is selected as one of the most promising start ups in Spain Read full article here (in Catalan): https://www.leconomic.cat/article/1633835-la-tribu-que-cria-les-start-ups.html… Read More